Position in RIGL
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$4,407,728
-$1,482,638 QoQ
Shares Held
112,672
-48.3% QoQ
Ownership
0.603%
of shares outstanding
% of Portfolio
0.57%
of 13F equity value
Holder Rank
#30
of 156 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RIGL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GLOBEFLEX CAPITAL L P holds $30,619,322 across 13 Biotechnology names. RIGL ranks #2 (14.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
254,993 | $13,874,169 | |
| 2 | RIGL |
Rigel Pharmaceuticals Inc
This page
|
112,672 | $4,407,728 | |
| 3 | PBYI |
Puma Biotechnology, Inc.
|
382,807 | $3,104,564 | |
| 4 | ZVRA |
Zevra Therapeutics, Inc.
|
191,904 | $2,751,903 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
10,645 | $2,565,125 | |
| 6 | AGEN |
Agenus Inc
|
418,581 | $1,280,857 | |
| 7 | INCY |
Incyte Corp
|
8,654 | $981,017 | |
| 8 | ARVN |
Arvinas, Inc.
|
59,331 | $493,040 |
All Filings in RIGL
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,407,728 | 112,672 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $5,890,366 | 217,839 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $9,330,044 | 217,839 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $6,165,457 | 217,630 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $3,137,555 | 167,515 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $940,787 | 52,295 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $879,601 | 52,295 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $148,856 | 9,200 | Shares | Sole | 2024-11-13 | |
| No filing history on record for this holder in this stock. | ||||||